Trial Profile
A Study Examining Risk Factors Associated With Neutropenia In Multiple Myeloma Patients Receiving Lenalidomide Plus Dexamethasone Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 09 Nov 2016 New trial record